Alnylam Pharmaceuticals
ALNY
#635
Rank
NZ$56.92 B
Marketcap
$439.76
Share price
0.29%
Change (1 day)
80.27%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company